Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy ; volume:60 ; number:1 ; day:11 ; month:1 ; year:2024 ; pages:1-24 ; date:12.2024
The Egyptian journal of neurology, psychiatry and neurosurgery ; 60, Heft 1 (11.1.2024), 1-24, 12.2024
- Creator
-
Jadhav, Devika
Saraswat, Nikita
Vyawahare, Neeraj
Shirode, Devendra
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41983-023-00775-8
- URN
-
urn:nbn:de:101:1-2024032511474900600780
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jadhav, Devika
- Saraswat, Nikita
- Vyawahare, Neeraj
- Shirode, Devendra
- SpringerLink (Online service)
Other Objects (12)
Targeting psychologic stress signaling pathways in Alzheimer’s disease
Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer’s Disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alzheimer’s disease: targeting the glutamatergic system
Alzheimer’s disease: targeting the peripheral circulation
Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer’s disease
Unravelling the mechanotransduction pathways in Alzheimer’s disease
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s disease: Recommendations of the ISCTM Working Group
Golgi-targeting viscosity probe for the diagnosis of Alzheimer’s disease
Targeting psychologic stress signaling pathways in Alzheimer’s disease
Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer’s Disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alzheimer’s disease: targeting the glutamatergic system
Alzheimer’s disease: targeting the peripheral circulation
Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer’s disease
Unravelling the mechanotransduction pathways in Alzheimer’s disease
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s disease: Recommendations of the ISCTM Working Group
Golgi-targeting viscosity probe for the diagnosis of Alzheimer’s disease
Targeting psychologic stress signaling pathways in Alzheimer’s disease
Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer’s Disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alzheimer’s disease: targeting the glutamatergic system
Alzheimer’s disease: targeting the peripheral circulation
Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer’s disease
Unravelling the mechanotransduction pathways in Alzheimer’s disease
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s disease: Recommendations of the ISCTM Working Group